| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8922518 | Clinical and Translational Radiation Oncology | 2017 | 6 Pages |
Abstract
High Glut-1 in LACC is associated with poor outcome post CRT. If prospectively validated, Glut-1 may help select patients for more intensive treatment regimens.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Yada Kanjanapan, Siddhartha Deb, Richard J. Young, Mathias Bressel, Linda Mileshkin, Danny Rischin, Michael S. Hofman, Kailash Narayan, Shankar Siva,